Drugs Health Pharma

EMA approves Sanofi’s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

Read More
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More
Drugs Health Medical

NO2 in gas and propane stoves can cause asthma in children: Study

HQ Team May 4, 2024: A new research says that nitrogen dioxide gas (NO2) emitted by gas and propane stoves is likely to.

Read More
Drugs Health Pharma

Israel’s Teva in pact with Launch Therapeutics for asthma drug

Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

Read More
Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion  

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes.

Read More
Climate Health Pharma

Global air pollution wrecking human resistance to antibiotics

HQ Team August 13, 2023: Global air pollution can aid antibiotic resistance in humans, researchers from China and the UK found. They checked.

Read More
Medical Pharma

Lupin buys inhalation brands from Sunovion for $75m

Lupin buys two inhalation brands for $75million

Read More
X